This website uses cookies to improve your browsing experience. Please read our Privacy Policy for more information on what information we gather and how it is used.
Following our successful fundraise of $4.1 million (check out the Forbes article), a new wave of projects are in the pipeline to be funded. First up in 2023 is Brain Tissue Replacement Therapy with Jean Hebert
Exploring the Frontiers of Science: Breakthroughs, Funding Challenges, and Replication Crisis with Alaattin Kaya during The Aging Science podcast by VitaDAO
The Longevity field is starting the year strongly with new updated Hallmarks of aging, exactly 10 years after the original paper was published. So time to update your introduction slides with the figure we will see in every presentation for the next
As the end of the year is fast approaching we wanted to look back and appreciate all the effort and hard work of the researchers in the VitaDAO community - from students, postdocs and fellows to principal investigators
A multitude of discoveries and inventions throughout history have been made by people who were initially trained in one domain, but were able to make a significant contribution to a different field due to their ability to look at a problem with a uni
VitaDAO Letter: New collab with Research Hub, Symposium Recap & more
Inside:
A Recap of VitaDAO’s 2nd “Crypto meets Longevity Symposium” VitaDAO Fellowship Update
New VitaSpotlight Series: Rapamycin as a Promising Aging Intervention How to contribute to VitaDAO and ResearchHub’s Community Driven Paper
Meet DAO Membe
Rapamycin is the most promising aging intervention we currently have
It was in 1975 when scientists from Ayerst (now Pfizer) discovered a novel compound called rapamycin (also known as Sirolimus) in bacteria on Rapa Nui(Easter Island) in Chile. In 1999 rapamycin obtained FDA approval for the prevention of acute reject
Some species in the animal kingdom live extraordinarily long lives. They seem to be somehow protected from all the damage that we would expect to accumulate in aged tissues. Many are very large, like bowhead whales, and there is an established correl
Decentralized Technology Transfer: A Modern Framework to Empower Scientific Innovation
The transfer of technology (TT) is essential in turning intellectual property (IP) generated from innovative research into real-world applications that benefit the general public.
Welcome back to our monthly newsletter! This month we are excited to bring you an interview with Dr. Marco Demaria who has made some significant contributions to our understanding of cellular senescence.
We can all agree that the age-associated decline in physiological functionality and increased risk of developing diseases is terrible, but what can we do to treat, slow down or even prevent it?
We are announcing The Longevity Prize in collaboration with Foresight. A series of prizes to honor and accelerate progress in longevity and rejuvenation. The longevity prize encourages novel approaches for turning back our aging clocks.
Why do we age? Is aging a result of a genetic program encoded within each of our cells, or is it simply a consequence of damage accumulation throughout life?
Epigenetic Clocks: A Simple Lab Test Measuring Biological Age
Humans can instinctively recognize if someone appears older or younger than their age; so then, it should be apparent that many species, including humans, develop age-related changes at different rates.
The First Longevity Drugs might be already among us — Drug Repurposing to Fight Aging
We are getting quite good at extending lifespan, or at least we are getting quite good at extending the lifespan of laboratory animals as complex as mice.